526PTrial design and rationale for OPAL, a phase 2, randomized, double-blind study of apitegromab in patients aged <2 years with spinal muscular atrophy.
Saved in:
| Title: | 526PTrial design and rationale for OPAL, a phase 2, randomized, double-blind study of apitegromab in patients aged <2 years with spinal muscular atrophy. |
|---|---|
| Authors: | Servais, L.1,2 (AUTHOR), Crawford, T.3 (AUTHOR), Capocelli, K.4 (AUTHOR), Yao, B.4 (AUTHOR), Tirucherai, G.4 (AUTHOR), Xu, Y.4 (AUTHOR), Zhao, G.4 (AUTHOR), Marantz, J.4 (AUTHOR), Darras, B.5 (AUTHOR) |
| Source: | Neuromuscular Disorders. 2025 Supplement, Vol. 53, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 193863054 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 526PTrial design and rationale for OPAL, a phase 2, randomized, double-blind study of apitegromab in patients aged <2 years with spinal muscular atrophy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Servais%2C+L%2E%22">Servais, L.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Crawford%2C+T%2E%22">Crawford, T.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Capocelli%2C+K%2E%22">Capocelli, K.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yao%2C+B%2E%22">Yao, B.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tirucherai%2C+G%2E%22">Tirucherai, G.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Y%2E%22">Xu, Y.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+G%2E%22">Zhao, G.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marantz%2C+J%2E%22">Marantz, J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Darras%2C+B%2E%22">Darras, B.</searchLink><relatesTo>5</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Neuromuscular+Disorders%22">Neuromuscular Disorders</searchLink>. 2025 Supplement, Vol. 53, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193863054 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.nmd.2025.105615 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: 526PTrial design and rationale for OPAL, a phase 2, randomized, double-blind study of apitegromab in patients aged <2 years with spinal muscular atrophy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Servais, L. – PersonEntity: Name: NameFull: Crawford, T. – PersonEntity: Name: NameFull: Capocelli, K. – PersonEntity: Name: NameFull: Yao, B. – PersonEntity: Name: NameFull: Tirucherai, G. – PersonEntity: Name: NameFull: Xu, Y. – PersonEntity: Name: NameFull: Zhao, G. – PersonEntity: Name: NameFull: Marantz, J. – PersonEntity: Name: NameFull: Darras, B. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09608966 Numbering: – Type: volume Value: 53 Titles: – TitleFull: Neuromuscular Disorders Type: main |
| ResultId | 1 |